GeneSys Bio

Montefiascone, Italy

GeneSys Bio's portable AI system detects pathogens and AMR in < 30 mins with >98% sensitivity, replacing slow lab tests and saving lives.

Jun 2024

Grant

Top Investors

CDP Venture CapitalBerkeley SkyDeck FundLazio Innova

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are GeneSys Bio's investors?

GeneSys Bio's investors include CDP Venture Capital, Berkeley SkyDeck Fund, Lazio Innova.

Where is GeneSys Bio headquartered?

GeneSys Bio is headquartered in Montefiascone, Italy.

What does GeneSys Bio do?

GeneSys Bio's portable AI system detects pathogens and AMR in < 30 mins with >98% sensitivity, replacing slow lab tests and saving lives.

What stage is GeneSys Bio at?

GeneSys Bio is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 25, 2024.

MLA

"GeneSys Bio — Funding & Investors." VCBacked, June 25, 2024, https://www.vcbacked.co/company/genesys-bio. Accessed July 1, 2026.

APA

VCBacked. (2024). GeneSys Bio — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/genesys-bio

Wikipedia (cite web)

{{cite web |title=GeneSys Bio — Funding & Investors |url=https://www.vcbacked.co/company/genesys-bio |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 25, 2024.